Skip to content

Repligen RGEN Gross Profit

Discontinued — last reported Q1 '26

Gross Profit at other companies

TEC
Bio-TechneTECH
$208.29M-2.9%
Danaher logo
DanaherDHR
$3.59B+2.3%
Agilent Technologies logo
Agilent TechnologiesA
$990M+14.3%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$309.4M+1.1%
Entegris logo
EntegrisENTG
$380.8M+6.8%
Revvity logo
RevvityRVTY

Other financials

Income statement

See full
Revenue$194.3M+14.8%
Operating income$15.9M+142%
Net income$8.3M+42.9%
EPS (diluted)$0.15+50.0%

Balance sheet

See full
Cash & equivalents$582.7M-16.4%
Total debt$687.6M+346%
Total equity$2.1B+6.0%
Total assets$2.9B+2.8%

Cash flow

See full
Operating cash flow$28.3M+88.6%
CapEx$4.7M+32.2%
Free cash flow$23.6M+106%

Valuation

See full
Market cap$7.45B-7.1%
Enterprise value$7.55B+2.1%
P/E144.9×
P/S10.1×-0.1×

Profitability

See full
Gross margin49.5%+2.7pp
Operating margin1.5%-14.0pp
Net margin17.1%-3.7pp
FCF margin21.2%+6.1pp

Returns & leverage

See full
Return on equity2.5%+1.9pp
Debt / equity0.3×+0.2×
Current ratio9.2×+2.4×

Where this comes from

Calculated from Repligen’s reported figures.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's gross profit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Repligen's gross profit?
Repligen (RGEN) reported gross profit of $108.28M in Q1 2026.
How has Repligen's gross profit changed year-over-year?
Repligen's gross profit increased by 18.5% year-over-year, from $91.37M to $108.28M.
What is the long-term trend for Repligen's gross profit?
Over 2 years (2021 to 2023), Repligen's gross profit has grown at a -13.1% compound annual growth rate (CAGR), from $391.25M to $295.72M.
What does gross profit mean?
Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.